What are Medtronic's total assets?

Medtronic (MDT) holds $93.0B in total assets, up 1.5% year over year.

How much debt does Medtronic have?

Medtronic carries $29.2B in total debt against $49.5B of shareholders' equity, a debt-to-equity ratio of 0.57.

How much cash does Medtronic have?

Medtronic holds $1.9B in cash and equivalents.

Can Medtronic cover its short-term obligations?

Its current ratio is 2.54 — current assets exceed current liabilities.

Where does Medtronic's balance sheet data come from?

Every line is extracted from Medtronic's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Medtronic MDT Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q4 '26	Q3 '26	Q2 '26	Q1 '26	Q4 '25
Cash and cash equivalents	$1.95B-12.1%	$1.15B-7.5%	$1.28B-8.0%	$1.27B-2.9%	$2.22B+72.7%
Short-term investments	$7.27B+7.8%	$7.24B+8.3%	$7.05B+6.8%	$6.85B+4.8%	$6.75B+0.4%
Accounts receivable, net	$6.64B+2.0%	$6.36B+4.0%	$6.39B+2.1%	$6.26B+4.2%	$6.52B+6.3%
Inventories	$5.95B+8.7%	$6.31B+12.5%	$6.16B+12.4%	$5.89B+8.7%	$5.48B+5.0%
Raw materials	——	$1.23B+13.1%	$1.11B+8.4%	$1.07B+8.7%	$953M+5.1%
Work in process	——	$883M+12.9%	$853M+17.2%	$792M+13.8%	$744M+15.9%
Finished goods	——	$4.19B+12.1%	$4.2B+12.5%	$4.02B+7.8%	$3.78B+3.0%
Prepaid expenses and other current assets	$2.97B+4.0%	$3.02B+5.4%	$3.12B+15.3%	$2.95B+10.2%	$2.86B+10.6%
Trading assets	——	$1.55B-0.2%	$1.55B+4.9%	$1.42B-1.9%	——
Derivative assets	——	$536M-45.3%	$466M-20.9%	$335M-49.9%	$334M-49.3%
Total current assets	$24.79B+4.1%	$24.07B+6.9%	$24B+6.9%	$23.22B+5.8%	$23.81B+8.6%
Property and equipment, net	$7.42B+8.5%	$7.18B+8.9%	$7.16B+11.3%	$7.01B+11.5%	$6.84B+11.5%
Accumulated depreciation	——	$18.92B+10.4%	$18.47B+10.4%	$18.02B+10.4%	$17.55B+10.3%
Goodwill	$42.59B+2.0%	$41.89B+2.6%	$41.81B+1.6%	$42.01B+2.2%	$41.74B+1.8%
Intangible assets, net	$10.15B-13.0%	$10.34B-15.2%	$10.77B-13.3%	$11.22B-12.5%	$11.67B-11.8%
Deferred tax assets	$362M-10.2%	$365M-19.2%	$386M-18.4%	$416M-16.1%	$403M-21.7%
Other non-current assets	$4.15B+15.7%	$4.04B-4.9%	$3.75B-6.5%	$3.59B-11.7%	$3.58B-11.4%
Equity method investments	——	$730M-9.8%	$671M—	$697M—	$705M-17.9%
Available-for-sale securities	——	$3.13B-1.9%	$2.92B-10.1%	$3.02B-9.3%	——
Total investments	——	$50M-83.9%	$57M—	$50M—	$140M-55.0%
Equity securities	——	$50M-83.9%	$57M-81.7%	$50M-83.9%	$140M-55.0%
Total assets	$93.03B+1.5%	$91.49B+1.7%	$91.35B+1.4%	$90.97B+1.4%	$91.68B+1.9%
Accounts payable	$2.64B+8.0%	$2.57B+12.4%	$2.58B+8.6%	$2.56B+11.5%	$2.45B+1.6%
Accrued expenses	$3.63B-1.3%	$3.5B-0.6%	$3.15B-3.3%	$3.6B-0.2%	$3.68B+2.8%
Accrued compensation	$2.68B+6.5%	$2.58B+13.2%	$2.13B+12.5%	$2.02B+13.6%	$2.51B+5.9%
Deferred revenue	——	$400M0.0%	$300M-25.0%	$400M0.0%	——
Current portion of long-term debt	$1.79B-37.8%	$191M-92.7%	$1.42B-61.8%	$2.43B+56.5%	$2.87B+163%
Finance Lease Liability, Current	$6M0.0%	——	——	——	$6M0.0%
Contract liabilities	——	$468M+1.3%	$451M-3.4%	$442M-4.1%	$446M-1.5%
Income taxes payable	$914M-32.7%	$650M-42.2%	$650M-31.4%	$933M-12.2%	$1.36B+2.1%
Other current liabilities	——	$1.3B—	$1.3B—	$1.2B—	——
Derivative liabilities	——	——	——	——	$97M—
Total current liabilities	$11.66B-9.5%	$9.5B-19.8%	$9.94B-18.5%	$11.53B+12.1%	$12.88B+19.4%
Long-term debt	$26.17B+2.1%	$27.88B+16.2%	$27.68B+12.5%	$26.18B-0.5%	$25.64B+7.1%
Finance lease liabilities	$54M+3.8%	$58M+16.0%	$55M+10.0%	$51M-1.9%	$52M-5.5%
Other non-current liabilities	$2.06B+16.2%	$1.77B+15.5%	$1.76B+15.0%	$1.81B+23.3%	$1.77B+29.6%
Total liabilities	$42.96B-1.1%	$42.29B+4.8%	$42.49B+2.8%	$42.84B+3.0%	$43.42B+9.8%
Common stock	$0—	$2.6B0.0%	$2.6B0.0%	$2.6B0.0%	$0—
Additional paid-in capital	$20.93B+0.4%	$21.01B+0.5%	$20.86B+0.2%	$20.89B+0.4%	$20.83B-9.9%
Retained earnings	$32.64B+3.7%	$32.3B+3.1%	$32.07B+3.7%	$31.61B+3.5%	$31.48B+3.5%
Accumulated other comprehensive income (loss)	-$4.1B+4.3%	-$4.33B-52.5%	-$4.28B-31.5%	-$4.6B-35.0%	-$4.28B-29.1%
Noncontrolling interests	$609M+163%	$211M-7.5%	$204M-8.1%	$240M+12.7%	$232M+12.6%
Total stockholders' equity	$49.46B+3.0%	$48.99B-0.8%	$48.65B+0.3%	$47.89B-0.1%	$48.02B-4.4%
Total liabilities and stockholders' equity	$93.03B+1.5%	$91.49B+1.7%	$91.35B+1.4%	$90.97B+1.4%	$91.68B+1.9%
Available-for-Sale Debt Securities - Amortized Cost	——	$7.26B+6.5%	$7.05B+5.0%	$6.91B+3.3%	$6.83B-2.0%
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)	——	$1.55B-0.4%	$1.56B+4.8%	$1.43B-2.1%	——
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)	——	$1.9B-42.6%	$1.36B-56.5%	$2.43B-25.6%	$2.99B-30.3%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)	——	$1.9B-42.6%	$1.36B-56.5%	$2.43B-25.6%	$2.99B-30.3%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	——	$749M-12.1%	$760M-2.8%	$735M-8.5%	$814M-2.9%
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)	——	$749M-12.1%	$760M-2.8%	$735M-8.5%	$814M-2.9%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value	——	$1.9B-42.6%	$1.36B-56.5%	$2.43B-25.6%	$2.99B-30.3%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	——	$749M-12.1%	$760M-2.8%	$735M-8.5%	$814M-2.9%
Allowance for Doubtful Accounts	——	$207M+1.5%	$200M+2.6%	$204M+20.0%	$199M+15.0%
Allowance for Doubtful Accounts Receivable (Current)	——	$207M+1.5%	$200M+2.6%	$204M+20.0%	$199M+15.0%
Finished goods	——	$4.19B+12.1%	$4.2B+12.5%	$4.02B+7.8%	$3.78B+3.0%
Other current assets	$2.97B+4.0%	$3.02B+5.4%	$3.12B+15.3%	$2.95B+10.2%	$2.86B+10.6%
Derivative Assets - Fair Value	——	$536M-45.3%	$466M-20.9%	$335M-49.9%	$334M-49.3%
Derivative Assets - Net Reduction from Master Netting Arrangements	——	$204M+158%	$186M+73.8%	$181M+84.7%	——
Net Cash Collateral Received - Derivative Instruments	——	——	——	——	$125M—
Trading Securities in Marketable Securities	——	$730M-9.8%	$671M—	$697M—	$705M-17.9%
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)	——	$3.12B-4.3%	$2.91B-12.5%	$3.04B-11.5%	——
Deferred Tax Assets and Other Non-Current Assets	$4.15B+15.7%	$4.04B-4.9%	$3.75B-6.5%	$3.59B-11.7%	$3.58B-11.4%
Equity Securities (FV-NI) - Non-Current	——	$50M-83.9%	$57M—	$50M—	$140M-55.0%
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments	——	$730M-9.8%	$671M—	$697M—	$705M-17.9%
Equity Securities (Non-Current)	——	$50M-83.9%	$57M—	$50M—	$140M-55.0%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	$1.35B-10.1%	$1.35B-9.5%	$1.35B-8.9%	——
Finite Lived Intangible Assets - Gross	——	$28.98B-0.2%	$28.95B+0.1%	$28.95B+0.7%	$28.93B+0.6%
Investments - Amortized Cost Basis	——	$730M-9.8%	$671M—	$697M—	$705M-17.9%
Deferred tax assets	$3.94B-2.4%	$3.97B+9.8%	$3.86B+8.0%	$3.93B+10.6%	$4.04B+10.5%
Other intangible assets—net	$10.15B-13.0%	$10.34B-15.2%	$10.77B-13.3%	$11.22B-12.5%	$11.67B-11.8%
Other non-current assets	$4.15B+15.7%	$4.04B-4.9%	$3.75B-6.5%	$3.59B-11.7%	$3.58B-11.4%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$7.27B+7.8%	$7.24B+8.3%	$7.05B+6.8%	$6.85B+4.8%	$6.75B+0.4%
Software and Technology Licenses, Net	$4.15B+15.7%	$4.04B-4.9%	$3.75B-6.5%	$3.59B-11.7%	$3.58B-11.4%
Accrued Contingent Liabilities	——	$200M0.0%	$200M0.0%	$200M-33.3%	$400M+100%
Accrued Income Taxes, Current	$914M-32.7%	$650M-42.2%	$650M-31.4%	$933M-12.2%	$1.36B+2.1%
Other accrued liabilities	$3.63B-1.3%	$3.5B-0.6%	$3.15B-3.3%	$3.6B-0.2%	$3.68B+2.8%
Derivative Liabilities - Fair Value	——	$388M+391%	$349M+217%	$523M+434%	$97M+47.0%
Derivative Liabilities - Not Offset Policy Election Deduction	——	——	——	——	$195M—
Derivative Liabilities Offset	——	——	——	——	$195M—
Debt Maturity - 5 to 10 Years	——	$1.16B+49.6%	$1.17B+55.7%	$1.11B+62.8%	——
Debt Maturity - Over 10 Years	——	$1.43B+17.8%	$1.43B+24.7%	$1.34B+20.6%	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	——	$118M-2.5%	$122M-2.4%	$113M-12.4%	$117M+6.4%
Defined Benefit Pension Plan Liabilities (Non-Current)	$1.19B+3.0%	$1.19B+12.0%	$1.18B+9.2%	$1.18B+6.5%	$1.16B+5.2%
Long-Term Debt and Finance Lease Obligations	$26.17B+2.1%	$27.88B+16.2%	$27.68B+12.5%	$26.18B-0.5%	$25.64B+7.1%
Liability For Uncertain Tax Positions Noncurrent	——	$2B—	——	——	$1.9B—
Retirement and nonpension postretirement benefit obligations	$1.19B+3.0%	$1.19B+12.0%	$1.18B+9.2%	$1.18B+6.5%	$1.16B+5.2%
Secured Borrowings Cash Right to Reclaim	——	——	——	——	$125M—
Unrecognized Tax Benefits	——	$2.9B0.0%	$2.9B0.0%	$2.9B+3.6%	$2.9B+3.6%
Unrecognized Tax Benefits - Impacting Effective Tax Rate	——	$2.7B0.0%	$2.7B0.0%	$2.7B0.0%	——
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued	——	$36M-42.9%	$50M+11.1%	$99M—	$74M—
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss	——	$47M-62.4%	$48M-62.5%	$75M-53.7%	$91M-61.8%
Common Stock Par Value Per Share	——	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	——	1.3B0.0%	1.3B0.0%	1.3B0.0%	1.3B-2.2%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$0—	$0—	$0—	$0—	$0—
Unrealized Gains on Investments	——	$54M+260%	$72M+227%	$33M+83.3%	$26M+271%
Unrealized Losses on Investments (Before Tax)	——	$55M-59.0%	$57M-58.7%	$84M-51.7%	$100M-60.3%
Fair Value Measurement Disclosure	——	$388M+391%	$349M+217%	$523M+434%	$417M+532%
Gross Assets/Liabilities	——	$388M+391%	$349M+217%	$523M+434%	$417M+532%
Income taxes payable – long-term	$1.52B-3.7%	$1.59B+6.9%	$1.54B+7.5%	$1.72B-10.2%	$1.57B-15.3%
Allowance for doubtful accounts	——	$207M+1.5%	$200M+2.6%	$204M+20.0%	$199M+15.0%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	——	$55M-59.0%	$57M-58.7%	$84M-51.7%	$100M-60.3%
Gross Unrealized Gains	——	$54M+260%	$72M+227%	$33M+83.3%	$26M+271%
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	$1.15B+47.1%	$1.15B+53.1%	$1.11B+61.3%	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	$1.16B+49.6%	$1.17B+55.7%	$1.11B+62.8%	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	$3.12B-4.3%	$2.91B-12.5%	$3.04B-11.5%	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	$3.13B-1.9%	$2.92B-10.1%	$3.02B-9.3%	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10	——	$1.43B+17.8%	$1.43B+24.7%	$1.34B+20.6%	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10	——	$1.42B+19.9%	$1.42B+27.3%	$1.31B+22.2%	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One	——	$1.55B-0.4%	$1.56B+4.8%	$1.43B-2.1%	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	——	$1.55B-0.2%	$1.55B+4.9%	$1.42B-1.9%	——
Common stock, par value (in dollars per share)	——	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	——	$2.6B0.0%	$2.6B0.0%	$2.6B0.0%	$2.6B0.0%
Common stock, shares issued (in shares)	——	$1.28B0.0%	$1.28B0.0%	$1.28B0.0%	$1.28B-2.2%
Common Stock, Shares, Outstanding	——	$1.28B0.0%	$1.28B0.0%	$1.28B0.0%	$1.28B-2.2%
Contract with Customer, Liability	——	$468M+1.3%	$451M-3.4%	$442M-4.1%	$446M-1.5%
Short-term debt and current portion of long-term debt	$1.79B-37.8%	$191M-92.7%	$1.42B-61.8%	$2.43B+56.5%	$2.87B+163%
Debt Instrument, Unamortized Discount (Premium), Net	——	$58M+13.7%	$59M+5.4%	$61M+1.7%	$59M+7.3%
Cost or Amortized Cost	——	$7.26B+6.5%	$7.05B+5.0%	$6.91B+3.3%	——
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss	——	$7.26B+6.5%	$7.05B+5.0%	$6.91B+3.3%	$6.83B-2.0%
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	——	$47M-62.4%	$48M-62.5%	$75M-53.7%	$91M-61.8%
Less than 12 months	——	$749M-12.1%	$760M-2.8%	$735M-8.5%	$814M-2.9%
12 months or more	——	$1.9B-42.6%	$1.36B-56.5%	$2.43B-25.6%	$2.99B-30.3%
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	——	$7M-22.2%	$10M0.0%	$9M-25.0%	$9M-35.7%
Estimated Fair Value	——	$7.26B+8.3%	$7.06B+7.1%	$6.86B+5.0%	$6.75B+0.4%
Deferred income taxes	$362M-10.2%	$365M-19.2%	$386M-18.4%	$416M-16.1%	$403M-21.7%
Derivative Asset (Liability), Fair Value, Gross Asset (Liability)	——	$149M-83.5%	$117M-75.6%	-$188M-133%	-$84M-114%
Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash	——	-$115M-142%	-$87M-267%	-$194M-311%	-$125M-224%
Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction	——	$0—	$0—	$0—	$0—
Derivative, Fair Value, Amount Offset Against Collateral, Net	——	$264M-58.0%	$204M-52.3%	$6M-98.7%	$42M-91.5%
Derivative, gross, assets	——	$536M-45.3%	$466M-20.9%	$335M-49.9%	$334M-49.3%
Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction	——	$333M-47.1%	$280M-35.2%	$154M-67.7%	——
Derivatives, gross, liabilities	——	$388M+391%	$349M+217%	$523M+434%	$417M+532%
Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction	——	——	——	——	$97M—
Derivative Liability	——	$388M+391%	$349M+217%	$523M+434%	$417M+532%
Potential reduction in net position of total derivative liabilities	——	——	——	——	$195M—
Equity method investments (Note 11)	——	$79M+2.6%	$83M—	$83M—	$89M+6.0%
Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, And Equity Method Investments	——	$1B-18.5%	$851M—	$850M—	$951M-25.8%
Trading securities, cost	——	$730M-9.8%	$671M—	$697M—	$705M-17.9%
Current maturities of long-term debt	$6M0.0%	——	——	——	$6M0.0%
Finite-Lived Intangible Assets, Accumulated Amortization	——	$18.92B+10.4%	$18.47B+10.4%	$18.02B+10.4%	$17.55B+10.3%
2028	——	$1.56B-4.2%	$1.56B-3.7%	$1.56B-3.0%	——
2030	——	$1.35B-10.1%	$1.35B-9.5%	$1.35B-8.9%	——
2031	——	$1.27B-7.1%	$1.27B-6.6%	$1.27B-5.7%	——
Remainder of 2026	——	$405M-2.2%	$846M+2.7%	$1.3B+6.2%	——
2027	——	$1.61B-2.4%	$1.61B-2.0%	$1.61B-1.3%	——
2029	——	$1.48B-6.0%	$1.48B-5.6%	$1.48B-4.8%	——
Gross Carrying Amount	——	$28.98B-0.2%	$28.95B+0.1%	$28.95B+0.7%	$28.93B+0.6%
Guarantor obligations, current carrying value	——	$1.3B—	$1.3B—	$1.2B—	——
Long-Term Debt and Lease Obligation	$26.17B+2.1%	$27.88B+16.2%	$27.68B+12.5%	$26.18B-0.5%	$25.64B+7.1%
Loss Contingency Accrual	——	$200M0.0%	$200M0.0%	$200M-33.3%	$400M+100%
Noncontrolling interests in subsidiaries	$609M+163%	$211M-7.5%	$204M-8.1%	$240M+12.7%	$232M+12.6%
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	$400M0.0%	$300M-25.0%	$400M0.0%	——
After-tax net unrealized gains (losses) associated with cash flow hedging instruments recorded in AOCI	——	-$116M—	-$108M—	-$276M—	-$149M—
Unrecognized tax benefits	——	$2.9B0.0%	$2.9B0.0%	$2.9B+3.6%	$2.9B+3.6%
Penalties and interest accrued on unrecognized tax benefits	——	$36M-42.9%	$50M+11.1%	$99M—	$74M—
Amount that if recognized, would affect the effective tax rate or regulatory liability	——	$2.7B0.0%	$2.7B0.0%	$2.7B0.0%	——
Remainder of Fiscal Year 2024	——	$405M-2.2%	$846M+2.7%	$1.3B+6.2%	——
Remainder of Fiscal Year 2025	——	$405M-2.2%	$846M+2.7%	$1.3B+6.2%	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Medtronic.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Medtronic's total assets?: Medtronic (MDT) holds $93.0B in total assets, up 1.5% year over year.
How much debt does Medtronic have?: Medtronic carries $29.2B in total debt against $49.5B of shareholders' equity, a debt-to-equity ratio of 0.57.
How much cash does Medtronic have?: Medtronic holds $1.9B in cash and equivalents.
Can Medtronic cover its short-term obligations?: Its current ratio is 2.54 — current assets exceed current liabilities.
Where does Medtronic's balance sheet data come from?: Every line is extracted from Medtronic's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.